[Sweet's syndrome and multiple myeloma].
Borbujo
J
J
de Lucas
R
R
Manzano
R
R
Casado
M
M
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D006801:Humans; D007146:Immunoglobulin lambda-Chains / Q000276:immunology; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D011241:Prednisone / Q000008:administration & dosage; D016463:Sweet Syndrome / Q000150:complications* / Q000188:drug therapy; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D007146:Immunoglobulin lambda-Chains; D008558:Melphalan; D011241:Prednisone
Síndrome de sweet y mieloma múltiple.